Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2022)

Historic Income from Non-Controlling Interests for Cytek Biosciences (CTKB) over the last 2 years, with Q4 2022 value amounting to $189000.0.

  • Cytek Biosciences' Income from Non-Controlling Interests rose 62692.31% to $189000.0 in Q4 2022 from the same period last year, while for Dec 2023 it was $189000.0, marking a year-over-year decrease of 5153.85%. This contributed to the annual value of -$92000.0 for FY2022, which is 45384.62% down from last year.
  • Latest data reveals that Cytek Biosciences reported Income from Non-Controlling Interests of $189000.0 as of Q4 2022, which was up 62692.31% from -$40000.0 recorded in Q3 2022.
  • In the past 5 years, Cytek Biosciences' Income from Non-Controlling Interests registered a high of $189000.0 during Q4 2022, and its lowest value of -$40000.0 during Q3 2022.